The efficacious hgp10025–33-pulsed bm12 mBMDC vaccine increased tumor-infiltrating hgp100/H2Db tetramer+ active CD8+ T cells and Th1 cells in tumors (Figure 1, F–H), suggesting improved cooperation between CD4+ and CD8+ T cells. This evidence concerns the gene CD4 and neoplasm.